297 related articles for article (PubMed ID: 16532445)
1. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
Nichols WC; Uniacke SK; Pankratz N; Reed T; Simon DK; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T;
Mov Disord; 2004 Jun; 19(6):649-55. PubMed ID: 15197702
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Nurr1 nucleotide variations in familial Parkinson's disease.
Levecque C; Destée A; Mouroux V; Amouyel P; Chartier-Harlin MC
Neurosci Lett; 2004 Aug; 366(2):135-8. PubMed ID: 15276233
[TBL] [Abstract][Full Text] [Related]
4. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
[TBL] [Abstract][Full Text] [Related]
5. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
Shabbeer J; Robinson M; Desnick RJ
Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
[TBL] [Abstract][Full Text] [Related]
6. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.
Zheng K; Heydari B; Simon DK
Arch Neurol; 2003 May; 60(5):722-5. PubMed ID: 12756136
[TBL] [Abstract][Full Text] [Related]
7. Mutations in NR4A2 associated with familial Parkinson disease.
Le WD; Xu P; Jankovic J; Jiang H; Appel SH; Smith RG; Vassilatis DK
Nat Genet; 2003 Jan; 33(1):85-9. PubMed ID: 12496759
[TBL] [Abstract][Full Text] [Related]
8. Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.
Sánchez-Ferrero E; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Alvarez V
Parkinsonism Relat Disord; 2009 Jul; 15(6):468-70. PubMed ID: 18980857
[TBL] [Abstract][Full Text] [Related]
9. Nurr1 mutational screen in Parkinson's disease.
Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y
Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059
[TBL] [Abstract][Full Text] [Related]
10. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
11. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.
Klein C; Djarmati A; Hedrich K; Schäfer N; Scaglione C; Marchese R; Kock N; Schüle B; Hiller A; Lohnau T; Winkler S; Wiegers K; Hering R; Bauer P; Riess O; Abbruzzese G; Martinelli P; Pramstaller PP
Eur J Hum Genet; 2005 Sep; 13(9):1086-93. PubMed ID: 15970950
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
Alvarez V; Corao AI; Sánchez-Ferrero E; De Mena L; Alonso-Montes C; Huerta C; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; García-Castro M; Coto E
Neurosci Lett; 2008 Feb; 432(1):79-82. PubMed ID: 18248889
[TBL] [Abstract][Full Text] [Related]
13. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
14. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
Berg D; Niwar M; Maass S; Zimprich A; Möller JC; Wuellner U; Schmitz-Hübsch T; Klein C; Tan EK; Schöls L; Marsh L; Dawson TM; Janetzky B; Müller T; Woitalla D; Kostic V; Pramstaller PP; Oertel WH; Bauer P; Krueger R; Gasser T; Riess O
Mov Disord; 2005 Sep; 20(9):1191-4. PubMed ID: 15895422
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4.
Hiramoto K; Kawakami H; Inoue K; Seki T; Maruyama H; Morino H; Matsumoto M; Kurisu K; Sakai N
Mov Disord; 2006 Sep; 21(9):1355-60. PubMed ID: 16763984
[TBL] [Abstract][Full Text] [Related]
17. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease.
Pang CP; Zhang J; Woo J; Chan D; Law LK; Tong SF; Kwok T; Kay R
Mov Disord; 1998 May; 13(3):529-32. PubMed ID: 9613747
[TBL] [Abstract][Full Text] [Related]
18. Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.
Yu B; Sawyer NA; Caramins M; Yuan ZG; Saunderson RB; Pamphlett R; Richmond DR; Jeremy RW; Trent RJ
J Clin Pathol; 2005 May; 58(5):479-85. PubMed ID: 15858117
[TBL] [Abstract][Full Text] [Related]
19. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.
Jankovic J; Chen S; Le WD
Prog Neurobiol; 2005; 77(1-2):128-38. PubMed ID: 16243425
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography.
Etokebe GE; Abrahamsen TG; Bogen B; Spurkland A
Scand J Immunol; 2004 May; 59(5):496-503. PubMed ID: 15140060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
